Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pharmacology research & perspectives [Pharmacol Res Perspect] NLMUID: 101626369"" wg kryterium: JN


Tytuł :
An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Autorzy :
Masuka JT; Harare Central Hospital, Southerton, Harare, Zimbabwe.; Department of Dermatology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Congella, Durban, South Africa.
Khoza S; Discipline of Pharmacology and Clinical Pharmacy, School of Pharmacy, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00657.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein.
Autorzy :
de With SAJ; Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
Man WH; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Clinical Pharmacy, Meander Medical Center, Amersfoort, The Netherlands.
Maas C; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Ten Berg M; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Cahn W; Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
Koekman AC; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
van Solinge WW; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Tak T; Department of Respiratory Medicine, Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00627.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
Autorzy :
Ooeda K; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Kubiura-Ichimaru M; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Tsuji S; Reagents Business, KAC Co., Amagasaki, Japan.
Okuyama S; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Yamashita M; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Mine A; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Kawamura F; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Ueyama T; Reagents Business, KAC Co., Amagasaki, Japan.
Tada M; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00652.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Arctigenin protects mice from thioglycollate-induced acute peritonitis.
Autorzy :
Zhao J; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Chen Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Dong L; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Li X; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Dong R; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Zhou D; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Wang C; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Guo X; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Zhang J; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Xue Z; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Xi Q; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Zhang L; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Yang G; Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.
Li Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Zhang R; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Institute of Basic Medical Sciences and Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00660.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.
Autorzy :
Heister PM; University of Cambridge, Cambridge, United Kingdom.
Poston RN; Queen Mary University of London, London, United Kingdom.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00653.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiviral Agents/*administration & dosage
Benzylisoquinolines/*administration & dosage
Betacoronavirus/*drug effects
Calcium Channel Blockers/*administration & dosage
Calcium Channels/*drug effects
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Animals ; Antiviral Agents/adverse effects ; Benzylisoquinolines/adverse effects ; Betacoronavirus/pathogenicity ; Calcium Channel Blockers/adverse effects ; Calcium Channels/metabolism ; Coronavirus Infections/diagnosis ; Coronavirus Infections/metabolism ; Coronavirus Infections/virology ; Drug Interactions ; Host-Pathogen Interactions ; Humans ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/virology ; Signal Transduction
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Comparing direct acting antivirals for hepatitis C using observational data - Why and how?
Autorzy :
Young J; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, Glen Site, McGill University Health Centre, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada.; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.
Wong S; British Columbia Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Janjua NZ; British Columbia Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, Glen Site, McGill University Health Centre, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00650.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
Autorzy :
El-Shabrawy M; Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Mishriki A; Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Attia H; Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Emad Aboulhoda B; Department of Anatomy and Embryology, Faculty of medicine, Cairo University, Cairo, Egypt.
Emam M; Department of Histopathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Wanas H; Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt.; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Taibah University, Madinah, Saudi Arabia.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00659.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.
Autorzy :
Franco JS; Medical Affairs, Bayer S.A, Bogotá, Colombia.
Vizcaya D; Epidemiology, Bayer Hispania, Barcelona, Spain.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00661.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
A novel approach to nonsurgical sterilization; application of menadione-modified gonocyte-targeting M13 bacteriophage for germ cell ablation in utero.
Autorzy :
Fraser BA; Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia.; Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Miller K; Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia.; Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Trigg NA; Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia.; Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Smith ND; Analytical and Biomolecular Research Facility, The University of Newcastle, Callaghan, NSW, Australia.
Western PS; Centre for Reproductive Health, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
Nixon B; Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia.; Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Aitken RJ; Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia.; Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.; Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00654.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports.
Autorzy :
Fernandez S; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals & University of Geneva, Geneva, Switzerland.
Lenoir C; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals & University of Geneva, Geneva, Switzerland.
Samer C; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals & University of Geneva, Geneva, Switzerland.
Rollason V; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals & University of Geneva, Geneva, Switzerland.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00647.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?
Autorzy :
Gusella M; Oncology Unit, AULSS5 Polesana, Rovigo, Italy.
Pasini F; Oncology Unit, Casa di Cura Pederzoli, Peschiera del Garda, Italy.
Corso B; National Research Council, Neuroscience Institute, Padova, Italy.
Bertolaso L; Oncology Unit, AULSS5 Polesana, Rovigo, Italy.
De Rosa G; Clinical Pharmacology Unit of the Department of Medicine (DIMED), University of Padova, Padova, Italy.
Falci C; Oncology Unit 2, Istituto Oncologico Veneto (IOV), IRCCS Padova, Padova, Italy.
Modena Y; Oncology Unit, AULSS5 Polesana, Rovigo, Italy.
Barile C; Oncology Unit, AULSS5 Polesana, Rovigo, Italy.
Da Corte Z D; Oncology Unit, Ospedale di Belluno, Belluno, Italy.
Fraccon A; Oncology Unit, Casa di Cura Pederzoli, Peschiera del Garda, Italy.
Toso S; Oncology Unit, Ospedale di Adria, Polesana, Italy.
Cretella E; Oncology Unit, Ospedale di Bolzano, Bolzano, Italy.
Brunello A; Oncology Unit 1, Istituto Oncologico Veneto (IOV), IRCCS Padova, Padova, Italy.
Modonesi C; Oncology Unit, Ospedali Riuniti Padova Sud, Padova, Italy.
Segati R; Oncology Unit, Ospedale di Feltre, Feltre, Italy.
Oliani C; Oncology Unit, AULSS5 Polesana, Rovigo, Italy.
Minicuci N; National Research Council, Neuroscience Institute, Padova, Italy.
Padrini R; Clinical Pharmacology Unit of the Department of Medicine (DIMED), University of Padova, Padova, Italy.
Pokaż więcej
Corporate Authors :
Italian TAM Group
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00646.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Medication-related problems and adverse drug reactions in Ethiopia: A systematic review.
Autorzy :
Kefale B; Clinical Pharmacy Unit and Research team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Amhara, Ethiopia.
Degu A; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, Kenya.
Tegegne GT; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00641.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
The metabolic effects of mirabegron are mediated primarily by β 3 -adrenoceptors.
Autorzy :
Dehvari N; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Sato M; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Bokhari MH; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Kalinovich A; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Ham S; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Gao J; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Nguyen HTM; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Whiting L; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Mukaida S; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Merlin J; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Chia LY; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Wootten D; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Summers RJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Evans BA; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Bengtsson T; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Hutchinson DS; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic., Australia.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00643.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte model.
Autorzy :
Gao B; Translational Safety & Bioanalytical Sciences, Amgen Inc., Thousand Oaks, CA, USA.
Sutherland W; Translational Safety & Bioanalytical Sciences, Amgen Inc., Thousand Oaks, CA, USA.
Vargas HM; Translational Safety & Bioanalytical Sciences, Amgen Inc., Thousand Oaks, CA, USA.
Qu Y; Translational Safety & Bioanalytical Sciences, Amgen Inc., Thousand Oaks, CA, USA.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00656.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Antiallodynic effect of PhAR-DBH-Me involves cannabinoid and TRPV1 receptors.
Autorzy :
Quiñonez-Bastidas GN; Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Ciudad de México, México.
Palomino-Hernández O; Computational Biomedicine - Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Forschungszentrum Jülich, Jülich, Germany.; Department of Chemistry, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.
López-Ortíz M; Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), México, DF, México.
Rocha-González HI; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México, Ciudad de México, México.
González-Anduaga GM; Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Ciudad de México, México.
Regla I; Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), México, DF, México.
Navarrete A; Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Ciudad de México, México.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00663.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Autorzy :
Ben-Eltriki M; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Green CJ; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Maclure M; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Musini V; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Bassett KL; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Wright JM; Therapeutics Initiative, Drug Assessment Working Group, University of British Columbia, Vancouver, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00651.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Real-time fluorometric evaluation of hepatoblast proliferation in vivo and in vitro using the expression of CYP3A7 coding for human fetus-specific P450.
Autorzy :
Okuyama S; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Kawamura F; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.; Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Japan.
Kubiura M; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Tsuji S; Chromosome Engineering Research Center, Tottori University, Yonago, Japan.
Osaki M; Chromosome Engineering Research Center, Tottori University, Yonago, Japan.
Kugoh H; Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Japan.; Chromosome Engineering Research Center, Tottori University, Yonago, Japan.
Oshimura M; Chromosome Engineering Research Center, Tottori University, Yonago, Japan.
Kazuki Y; Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Japan.; Chromosome Engineering Research Center, Tottori University, Yonago, Japan.
Tada M; Stem Cells & Reprogramming Laboratory, Department of Biology, Faculty of Science, Toho University, Funabashi, Japan.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00642.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Sentiment analysis of social media posts on pharmacotherapy: A scoping review.
Autorzy :
Sharma C; Rheumatology, Fiona Stanley Hospital, Perth, Australia.
Whittle S; Rheumatology, The Queen Elizabeth Hospital, Adelaide, Australia.
Haghighi PD; Faculty of Information Technology, Monash University, Melbourne, Australia.
Burstein F; Faculty of Information Technology, Monash University, Melbourne, Australia.
Keen H; Rheumatology, Fiona Stanley Hospital, Perth, Australia.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00640.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.
Autorzy :
Buawangpong N; Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Teekachunhatean S; Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Koonrungsesomboon N; Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Musculoskeletal Science and Translational Research Center, Chiang Mai University, Chiang Mai, Thailand.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00644.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature.
Autorzy :
Froese L; Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Canada.
Dian J; Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Gomez A; Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Department of Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Unger B; Section of Critical Care, Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Zeiler FA; Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Canada.; Department of Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Centre on Aging, University of Manitoba, Winnipeg, Canada.; Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00655.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies